Ask a Pharmacist

An exit strategy for opioid therapy

January 26, 2012

What exit strategy do you recommend for discontinuing opioid therapy?
 

Impact of CYP3A4 pathway

January 26, 2012

How does the CYP3A4 pathway impact metabolism of the new oral targeted agents in oncology?
 

The effect of pentamidine on glucose

December 19, 2011

What effect does pentamidine have on glucose control?
 

Addressing drug shortages

December 19, 2011

What actions are being taken in regard to current shortages of chemotherapeutic agents?
 

Should a test 
dose of 
bleomycin 
be given? 
If yes, when?

October 21, 2011

Should patients receive a test dose of bleomycin? If yes, should the test dose be administered with every dose or just the initial dose?
 

Managing the effects of chemo brain and food-drug interactions

July 13, 2011

How can chemo brain be managed? Can citrus juices interfere with drug metabolism?
 

Clinical data on effectiveness of Hawaiian noni fruit are insufficient

May 20, 2011

What data are there to support the use of noni in oncology patients? Can it be incorporated safely with chemotherapy?
 

Parenteral iron test doses and hot flushes on tamoxifen

March 16, 2011

Who should receive a test dose prior to a full-dose iron infusion? How can hot flushes be managed in women on tamoxifen therapy?
 

Drug-related skeletal effects and managing vaginal dryness

January 18, 2011

What should nurses be aware of when administering denosumab? What are the best strategies for managing vaginal dryness caused by hormonal therapy for breast cancer?
 

Managing cancer-related fatigue and drug-induced neuropathy

November 04, 2010

What role does medication play in managing fatigue? Can neuropathy from oxaliplatin therapy be effectively treated or prevented?
 

Two vital resources for melanoma management


Two myCME Webcasts, Management of Metastatic Melanoma and Management of Early Melanoma and Atypical Spitz Tumors, provide health care professionals with current and relevant research, treatment options, clinical data, guidance, and resources to optimize melanoma detection, management, patient care, and outcomes. Each Webcast offers 1.0 AMA PRA Category 1 CreditTM.

Free CE from mycme.com

Discussions on Emerging Concepts and Controversies in the Treatment of Patients with Advanced Non-Small Cell Lung Cancer

2.00 / AMA PRA Category 1 Credit(s)TM
This program reviews developments in maintenance therapy and evaluates the relevance of tumor histology and biomarker analysis for the management of NSCLC patients.
 
Visit Reflections for first-hand stories on the power of the patient to impact caregivers in oncology nursing.

FEBRUARY 3 - 4
• 2012 Highlights of ASH in North America
New York, New York
• 2012 Highlights of ASH in North America
San Francisco, California
MARCH 3 - 4
• 2012 Highlights of ASH in Asia
Singapore, Singapore
MAY 3 - 6
• 37th Annual ONS Congress
New Orleans, Louisiana

Let us know what you are looking for in a new oncology nursing journal:

Click here to take our survey

Web Exclusives

Psychosocial approach useful in managing cancer pain

February 03, 2012

Psychosocial interventions, including skills instruction and education, can help reduce pain in persons with cancer, confirm the results of a recent meta-analysis.
 

Experimental agent slows progression of colorectal cancer

February 02, 2012

The investigational drug regorafenib conferred a statistically significant survival benefit in patients with metastatic colorectal cancer in whom no standard therapy was effective.
 

In HER2 breast cancer, lapatinib works better with trastuzumab than without

February 01, 2012

Lapatinib is not as effective as trastuzumab against (HER2)-positive breast cancer, but combining the two nearly doubles the effectiveness seen with either one alone.
 

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions